Eight drugs added to less insurance coverage have less coverage on 8 drugs

Published: 2012-09-12 06:59:00

Updated: 2012-09-12 06:59:00

The Health Insurance Review and Assessment Service said Monday that eight medicines, including Ilyang Pharmaceutical’s Supect, a newly developed drug for myelogenous leukemia and Hanmi Pharmaceutical’s Rispidone, will be added to a list of 1,332 drugs that are subject to less insurance coverage, ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK